{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T19:31:02Z","timestamp":1792956662028,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pharmthera.2016.11.013","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T19:46:50Z","timestamp":1480621610000},"page":"50-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":264,"special_numbering":"C","title":["Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential"],"prefix":"10.1016","volume":"172","author":[{"given":"Alyssa","family":"Faria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta J","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2016.11.013_bb0005","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2147\/DDDT.S109287","article-title":"Sitagliptin attenuates cardiomyopathy by modulating the JAK\/STAT signaling pathway in experimental diabetic rats","volume":"10","author":"Al-Rasheed","year":"2016","journal-title":"Drug Design, Development and Therapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.yjmcc.2005.04.008","article-title":"Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure","volume":"39","author":"Amado","year":"2005","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"15","key":"10.1016\/j.pharmthera.2016.11.013_bb0015","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/01.CIR.0000065637.10517.A0","article-title":"Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging","volume":"107","author":"Anker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.freeradbiomed.2016.06.019","article-title":"Mitochondrial Peroxiredoxin-3 protects against hyperglycemia induced myocardial damage in diabetic cardiomyopathy","volume":"97","author":"Arkat","year":"2016","journal-title":"Free Radical Biology and Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.11.013_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.avdiab.2011.08.002","article-title":"Cardiomyopathy in diabetics: A review of current opinion on the underlying pathological mechanisms","volume":"27","author":"Ashrafi","year":"2011","journal-title":"Avances en Diabetolog\u00eda"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1152\/japplphysiol.00103.2008","article-title":"Exercise training initiated after the onset of diabetes preserves myocardial function: Effects on expression of \u03b2-adrenoceptors","volume":"105","author":"Bidasee","year":"2008","journal-title":"Journal of Applied Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/01.CIR.99.3.384","article-title":"Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart","volume":"99","author":"Bowling","year":"1999","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.11.013_bb0045","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI119755","article-title":"Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates","volume":"100","author":"Bowman","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0050","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.freeradbiomed.2004.05.034","article-title":"Mitochondrial superoxide: Production, biological effects, and activation of uncoupling proteins","volume":"37","author":"Brand","year":"2004","journal-title":"Free Radical Biology and Medicine"},{"issue":"6865","key":"10.1016\/j.pharmthera.2016.11.013_bb0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0060","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: A unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0065","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.CIR.0000109499.00587.FF","article-title":"N-acetylcysteine prevents the deleterious effect of tumor necrosis factor-\u03b1 on calcium transients and contraction in adult rat cardiomyocytes","volume":"109","author":"Cailleret","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2014.06.010","article-title":"Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications","volume":"95","author":"Chawla","year":"2014","journal-title":"Microvascular Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrendo.2011.183","article-title":"The worldwide epidemiology of type 2 diabetes mellitus-present and future perspectives","volume":"8","author":"Chen","year":"2012","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0080","first-page":"539","article-title":"The effects of tetrahydrobiopterin (BH4) treatment on brain function in individuals with phenylketonuria","volume":"3","author":"Christ","year":"2013","journal-title":"Neurologic Clinics"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.11.013_bb0085","first-page":"CD002141","article-title":"Drugs for preventing lung cancer in healthy people","author":"Cort\u00e9s-Jofr\u00e9","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.11.013_bb0090","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/jama.297.8.842","article-title":"Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis","volume":"297","author":"Bjelakovic","year":"2007","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1681\/ASN.2008050514","article-title":"RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes","volume":"20","author":"Coughlan","year":"2009","journal-title":"Journal of the American Society of Nephrology"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.11.013_bb0100","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.freeradbiomed.2011.03.010","article-title":"Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency","volume":"50","author":"Crabtree","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0167-5273(87)90080-5","article-title":"Specific heart muscle disease in diabetes mellitus\u2014A functional structural correlation","volume":"17","author":"Das","year":"1987","journal-title":"International Journal of Cardiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.11.013_bb0110","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.amjcard.2008.02.082","article-title":"Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population","volume":"101","author":"Eguchi","year":"2008","journal-title":"The American Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/hc3201.092284","article-title":"Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice","volume":"104","author":"Feng","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(80)90323-9","article-title":"Spin trapping of superoxide and hydroxyl radical: Practical aspects","volume":"200","author":"Finkelstein","year":"1980","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0125","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clinical Diabetes"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.11.013_bb0130","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/CIRCULATIONAHA.106.658948","article-title":"Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham heart study","volume":"115","author":"Fox","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1006\/abbi.1995.1122","article-title":"Hydroxyl radical generation during mitochondrial electron-transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial-DNA","volume":"316","author":"Giulivi","year":"1995","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0140","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/ATVBAHA.115.307012","article-title":"Reactive oxygen species can provide Atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling","volume":"36","author":"Gray","year":"2016","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0145","doi-asserted-by":"crossref","first-page":"H1728","DOI":"10.1152\/ajpheart.01328.2005","article-title":"Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-l-cysteine","volume":"292","author":"Guo","year":"2007","journal-title":"The American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.yjmcc.2009.02.021","article-title":"What is the mitochondrial permeability transition pore?","volume":"46","author":"Halestrap","year":"2009","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0155","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11064-016-1863-7","article-title":"Rutin inhibits neuroinflammation and provides neuroprotection in an experimental rat model of subarachnoid hemorrhage, possibly through suppressing the RAGE\u2013NF-\u03baB inflammatory signaling pathway","volume":"41","author":"Hao","year":"2016","journal-title":"Neurochemical Research"},{"issue":"24","key":"10.1016\/j.pharmthera.2016.11.013_bb0160","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","article-title":"Impact of oxypurinol in patients with symptomatic heart failure: Results of the OPT-CHF study","volume":"51","author":"Hare","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0165","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1751-7133.2011.00262.x","article-title":"Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition","volume":"18","author":"Harzand","year":"2012","journal-title":"Congestive Heart Failure"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/hh0102.102757","article-title":"Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction","volume":"90","author":"Heger","year":"2002","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1152\/physiolgenomics.00029.2005","article-title":"Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy","volume":"26","author":"Hingtgen","year":"2006","journal-title":"Physiological Genomics"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0180","first-page":"CD007435","article-title":"Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension","volume":"3","author":"Ho","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1139\/cjpp-2015-0073","article-title":"Mangiferin suppressed advanced glycation end products (AGEs) through NF-\u03baB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats","volume":"94","author":"Hou","year":"2016","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.11.013_bb0190","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00125-012-2495-3","article-title":"Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db\/db mouse model of type 2 diabetes","volume":"55","author":"Huynh","year":"2012","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.RES.85.4.357","article-title":"Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium","volume":"85","author":"Ide","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0200","unstructured":"IDF Diabetes Atlas, 7th Edition. http:\/\/www.diabetesatlas.org\/"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.11.013_bb0205","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.RES.0000126497.38281.23","article-title":"Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction","volume":"94","author":"Janssens","year":"2004","journal-title":"Circulation Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.11.013_bb0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1440-1681.2011.05535.x","article-title":"Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice","volume":"38","author":"Jo","year":"2011","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"issue":"19","key":"10.1016\/j.pharmthera.2016.11.013_bb0215","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.11.013_bb0220","doi-asserted-by":"crossref","first-page":"25234","DOI":"10.3390\/ijms161025234","article-title":"Diabetic cardiovascular disease induced by oxidative stress","volume":"16","author":"Kayama","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0225","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00049.2016","article-title":"Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress","volume":"311","author":"Koncsos","year":"2016","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.11.013_bb0230","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.bbadis.2015.08.001","article-title":"Oxidative stress, mitochondrial damage and diabetic retinopathy","volume":"1852","author":"Kowluru","year":"2015","journal-title":"Biochimica et Biophysica Acta-Molecular Basis of Disease"},{"issue":"35","key":"10.1016\/j.pharmthera.2016.11.013_bb0235","doi-asserted-by":"crossref","first-page":"15565","DOI":"10.1073\/pnas.1002178107","article-title":"NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart","volume":"107","author":"Kuroda","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0240","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","article-title":"Activation of NADPH oxidase during progression of cardiac hypertrophy to failure","volume":"40","author":"Li","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0245","doi-asserted-by":"crossref","first-page":"4323198","DOI":"10.1155\/2016\/4323198","article-title":"Elevated levels of urinary markers of oxidative DNA and RNA damage in type 2 diabetes with complications","volume":"2016","author":"Liu","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12872-015-0076-3","article-title":"N-acetyl cysteine improves the diabetic cardiac function: Possible role of fibrosis inhibition","volume":"15","author":"Liu","year":"2015","journal-title":"BMC Cardiovascular Disorders"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.11.013_bb0255","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.etp.2015.04.008","article-title":"Nobiletin ameliorates cisplatin-induced acute kidney injury due to its anti-oxidant, anti-inflammatory and anti-apoptotic effects","volume":"67","author":"Malik","year":"2015","journal-title":"Experimental and Toxicologic Pathology"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: Pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Failure Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0265","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO: A randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Failure"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0270","doi-asserted-by":"crossref","first-page":"10344","DOI":"10.1038\/srep10344","article-title":"Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: A double-blind randomized controlled trial","volume":"5","author":"Na","year":"2015","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.11.013_bb0275","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.98.8.794","article-title":"Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II","volume":"98","author":"Nakamura","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","article-title":"Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy","volume":"90","author":"Ni","year":"2016","journal-title":"Free Radical Biology and Medicine"},{"issue":"6779","key":"10.1016\/j.pharmthera.2016.11.013_bb0285","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.11.013_bb0290","doi-asserted-by":"crossref","first-page":"e003682","DOI":"10.1161\/JAHA.116.003682","article-title":"Aging-related decline of glutathione peroxidase 3 and risk of cardiovascular events in patients with atrial fibrillation","volume":"5","author":"Pastori","year":"2016","journal-title":"Journal of the American Heart Association"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.11.013_bb0295","doi-asserted-by":"crossref","first-page":"e78330","DOI":"10.1371\/journal.pone.0078330","article-title":"Sitagliptin reduces cardiac apoptosis, hypertrophy and fibrosis primarily by insulin-dependent mechanisms in experimental type-II diabetes. Potential roles of GLP-1 isoforms","volume":"8","author":"Picatoste","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor \u03b1 and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0305","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0310","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0315","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.phrs.2016.03.026","article-title":"Curcumin downregulates human tumor necrosis factor-\u03b1 levels: A systematic review and meta-analysis of randomized controlled trials","volume":"107","author":"Sahebkar","year":"2016","journal-title":"Pharmacological Research"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2016.11.013_bb0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-016-2767-1","article-title":"Cardioprotective effects of rutin via alteration in TNF-\u03b1, CRP, and BNP levels coupled with antioxidant effect in STZ-induced diabetic rats","volume":"420","author":"Saklani","year":"2016","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.11.013_bb0325","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","article-title":"Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase","volume":"110","author":"Schroder","year":"2012","journal-title":"Circulation Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0330","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2012.04.022","article-title":"Regulation of innate immunity by NADPH oxidase","volume":"53","author":"Segal","year":"2012","journal-title":"Free Radical Biology and Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.11.013_bb0335","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002713","article-title":"Lipid and blood pressure meta-analysis collaboration (LBPMC) group. Effects of quercetin on blood pressure: A systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Serban","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0340","doi-asserted-by":"crossref","first-page":"5868913","DOI":"10.1155\/2016\/5868913","article-title":"Exercise training attenuates upregulation of p47phox and p67phox in hearts of diabetic rats","volume":"2016","author":"Sharma","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0350","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00394-011-0188-1","article-title":"New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases","volume":"50","author":"Shehzad","year":"2011","journal-title":"European Journal of Nutrition"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.11.013_bb0355","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/db08-0617","article-title":"Rac1 is required for cardiomyocyte apoptosis during hyperglycemia","volume":"58","author":"Shen","year":"2009","journal-title":"Diabetes"},{"issue":"5 Pt 1","key":"10.1016\/j.pharmthera.2016.11.013_bb0360","first-page":"E783","article-title":"Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation","volume":"265","author":"Shiba","year":"1993","journal-title":"The American Journal of Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0365","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.biosystems.2007.05.005","article-title":"Complex systems biology approach to understanding coordination of JAK-STAT signaling","volume":"90","author":"Soebiyanto","year":"2007","journal-title":"Bio Systems"},{"issue":"5074","key":"10.1016\/j.pharmthera.2016.11.013_bb0370","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1355616","article-title":"Protein oxidation and aging","volume":"257","author":"Stadtman","year":"1992","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0375","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.11.013_bb0380","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2337\/db13-1896","article-title":"Arachidonate 12\/15-lipoxygenase-induced inflammation and oxidative stress are involved in the development of diabetic cardiomyopathy","volume":"64","author":"Suzuki","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0385","first-page":"CD006616","article-title":"N-acetylcysteine for sepsis and systemic inflammatory response in adults","volume":"9","author":"Szakmany","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.11.013_bb0390","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-014-3452-0","article-title":"Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunction","volume":"58","author":"Taylor-Fishwick","year":"2015","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.11.013_bb0395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/CS20150204","article-title":"Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy\/redox stress leads to myocardial dysfunction during type I diabetes","volume":"129","author":"Tocchetti","year":"2015","journal-title":"Clinical Science (London, England)"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.11.013_bb0400","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.11.013_bb0405","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"17","key":"10.1016\/j.pharmthera.2016.11.013_bb0410","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1073\/pnas.94.17.9320","article-title":"Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy","volume":"94","author":"Wakasaki","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.11.013_bb0415","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.11.013_bb0420","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2337\/diabetes.51.9.2709","article-title":"Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes","volume":"51","author":"Way","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.11.013_bb0425","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","article-title":"Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy","volume":"102","author":"Westermann","year":"2007","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0430","doi-asserted-by":"crossref","first-page":"27925","DOI":"10.1038\/srep27925","article-title":"Cardiomyocyte GTP cyclohydrolase 1 protects the heart against diabetic cardiomyopathy","volume":"6","author":"Wu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2016.11.013_bb0435","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12933-015-0176-5","article-title":"Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications","volume":"14","author":"Yamagishi","year":"2015","journal-title":"Cardiovascular Diabetology"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.11.013_bb0440","doi-asserted-by":"crossref","first-page":"e52013","DOI":"10.1371\/journal.pone.0052013","article-title":"Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats","volume":"7","author":"Yu","year":"2012","journal-title":"PloS One"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2016.11.013_bb0445","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-016-2716-z","article-title":"Nobiletin attenuates cardiac dysfunction, oxidative stress, and inflammatory in streptozotocin: Induced diabetic cardiomyopathy","volume":"417","author":"Zhang","year":"2016","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"6865","key":"10.1016\/j.pharmthera.2016.11.013_bb0450","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581630239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372581630239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T02:37:59Z","timestamp":1537843079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372581630239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":90,"alternative-id":["S016372581630239X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.11.013","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}